CMAB015

· Taizhou Mabtech Pharmaceutical Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMAB015, covering 2025-09-10 to 2025-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis [Phase 3]